Sunzen Biotech Bhd (0148) — Cash Flow Reinvestment Rate

Latest as of September 2023: 0.04x

Sunzen Biotech Bhd (0148) has a Cash Flow Reinvestment Rate of 0.04x as of September 2023, reinvesting RM145.00K (capex RM95.00K plus investments RM50.00K) from operating cash flow of RM3.58 Million. See Sunzen Biotech Bhd (0148) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.04x
(Capex + Investments) / Operating CF

Total Reinvested

RM145.00K
Capex + Investments

Operating Cash Flow

RM3.58 Million
MYR

Capital Expenditures

RM95.00K
MYR

Sunzen Biotech Bhd Cash Flow Reinvestment Rate (2016–2023)

Historical reinvestment intensity for Sunzen Biotech Bhd across 4 annual periods. For the full cash flow conversion analysis, see Sunzen Biotech Bhd operating cash flow efficiency.

Annual Cash Flow Reinvestment Rate for Sunzen Biotech Bhd (2016–2023)

Year-by-year capital reinvestment analysis for Sunzen Biotech Bhd. See how financially flexible is Sunzen Biotech Bhd to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (MYR) Operating CF Capex YoY Change
2023 2.96x RM2.43 Million RM819.39K RM1.01 Million ▲ +1495.8%
2020 0.19x RM1.34 Million RM7.20 Million RM1.16 Million ▼ -87.5%
2017 1.49x RM5.98 Million RM4.02 Million RM3.42 Million ▼ -95.7%
2016 34.76x RM8.90 Million RM256.13K RM6.64 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow